You had a situation where the amount of people who died from cancer were roughly the same in the US and Europe.
At the same time the US started diagnosis earlier and had a higher rate of curing people who are diagnosed with cancer. This does suggest that women got diagnosed in the US with cancer while they wouldn’t have been in Europe with lower testing rates but where whether or not they are treated had in the end little effect on mortality due to breast cancer.
If someone is good at making treatment decisions then he should get better outcomes if he gets more testing data. The fact that this didn’t seem to happen suggests a problem with the decision making of the cancer doctors.
It’s not definite but at the same time I don’t see evidence that the doctors are actually good at making decisions.
You had a situation where the amount of people who died from cancer were roughly the same in the US and Europe.
At the same time the US started diagnosis earlier and had a higher rate of curing people who are diagnosed with cancer. This does suggest that women got diagnosed in the US with cancer while they wouldn’t have been in Europe with lower testing rates but where whether or not they are treated had in the end little effect on mortality due to breast cancer.
If someone is good at making treatment decisions then he should get better outcomes if he gets more testing data. The fact that this didn’t seem to happen suggests a problem with the decision making of the cancer doctors.
It’s not definite but at the same time I don’t see evidence that the doctors are actually good at making decisions.